Literature DB >> 15326477

P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation.

Oriol Casanovas1, Montserrat Jaumot, Ana-Belén Paules, Neus Agell, Oriol Bachs.   

Abstract

Cyclin D3 plays a critical role in maturation of precursor T cells and their levels are tightly regulated during this process. Alteration of cyclin D3 levels has been proposed to be important in the development of different human cancers, including malignancies of the lymphoid system. Thus, we have analysed the mechanisms involved in the regulation of cyclin D3 levels. Our results indicate that cyclin D3 is degraded via proteasome and that Thr-283 is essential for its degradation. Wild-type cyclin D3 but not the Thr-283A mutant accumulated ubiquitylated forms after treatment with proteasome inhibitors. We also observed that different type of stresses promote the Thr-283-dependent in vivo degradation of cyclin D3. The analysis of the kinases involved in Thr-283 phosphorylation indicates that all the members of the p38SAPK family of serine-threonine kinases are able to phosphorylate cyclin D3 at this specific site. Moreover, we found that the overexpression of p38alphaSAPK2 induce the decrease of cyclin D3 in vivo. These results indicate that p38SAPK might be involved in the regulation of cyclin D3 levels and suggest that this mechanism is involved in the maturation of precursor T-cells. Alterations of this mechanism might be important for oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326477     DOI: 10.1038/sj.onc.1208040

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Reciprocal regulation of aquaporin-2 abundance and degradation by protein kinase A and p38-MAP kinase.

Authors:  Pavel I Nedvetsky; Vedrana Tabor; Grazia Tamma; Sven Beulshausen; Philipp Skroblin; Aline Kirschner; Kerim Mutig; Mareike Boltzen; Oscar Petrucci; Anna Vossenkämper; Burkhard Wiesner; Sebastian Bachmann; Walter Rosenthal; Enno Klussmann
Journal:  J Am Soc Nephrol       Date:  2010-08-19       Impact factor: 10.121

2.  mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability.

Authors:  Norman Balcazar; Aruna Sathyamurthy; Lynda Elghazi; Aaron Gould; Aaron Weiss; Ichiro Shiojima; Kenneth Walsh; Ernesto Bernal-Mizrachi
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

Review 3.  Cyclin D degradation by E3 ligases in cancer progression and treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  Semin Cancer Biol       Date:  2020-01-30       Impact factor: 15.707

4.  Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

Authors:  Sandrine Sander; Dinis P Calado; Lakshmi Srinivasan; Karl Köchert; Baochun Zhang; Maciej Rosolowski; Scott J Rodig; Karlheinz Holzmann; Stephan Stilgenbauer; Reiner Siebert; Lars Bullinger; Klaus Rajewsky
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

5.  p38 regulates pigmentation via proteasomal degradation of tyrosinase.

Authors:  Barbara Bellei; Vittoria Maresca; Enrica Flori; Angela Pitisci; Lionel Larue; Mauro Picardo
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

6.  Herpes simplex virus type 2 UL56 interacts with the ubiquitin ligase Nedd4 and increases its ubiquitination.

Authors:  Yoko Ushijima; Tetsuo Koshizuka; Fumi Goshima; Hiroshi Kimura; Yukihiro Nishiyama
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

7.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

8.  The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration.

Authors:  Jingling Jin; Guo-Li Wang; Xiurong Shi; Gretchen J Darlington; Nikolai A Timchenko
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

Review 9.  Oncogenic mechanisms in Burkitt lymphoma.

Authors:  Roland Schmitz; Michele Ceribelli; Stefania Pittaluga; George Wright; Louis M Staudt
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

10.  Preventing p38 MAPK-mediated MafA degradation ameliorates β-cell dysfunction under oxidative stress.

Authors:  Ilham El Khattabi; Arun Sharma
Journal:  Mol Endocrinol       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.